https://www.selleckchem.com/products/img-7289.html
06, p = 0.021). Women with PCOS and GDM had a higher body mass index (31.5 kg/m vs 27.7 kg/m , p 0.001), significant gestational weight gain (12.6 kg vs 11.5 kg, p = 0.016), and more frequent use of pharmacotherapies to manage their GDM (57.7% vs 45.2%, p 0.001). There was no statistically significant difference in the rates of adverse neonatal outcomes in both the groups. Among women with GDM, PCOS was an independent risk factor for the development of preeclampsia and significant gestational weight gain, warranting vigilant
Like
Comment
Share
